Last reviewed · How we verify
Hypertonic saline 3% bolus administration — Competitive Intelligence Brief
marketed
Osmotic agent
Neurology
Small molecule
Live · refreshed every 30 min
Target snapshot
Hypertonic saline 3% bolus administration (Hypertonic saline 3% bolus administration) — Université de Sherbrooke. Hypertonic saline 3% creates an osmotic gradient that draws fluid from intracellular and interstitial spaces into the intravascular compartment, reducing intracranial pressure and cellular edema.
Comparator set (6 drugs)
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Hypertonic saline 3% bolus administration TARGET | Hypertonic saline 3% bolus administration | Université de Sherbrooke | marketed | Osmotic agent | ||
| Sodium Chloride [3%] | Sodium Chloride [3%] | Fundacion Clinica Valle del Lili | marketed | Electrolyte solution / Osmotic agent | ||
| AS 50% eye drops 8*1 | AS 50% eye drops 8*1 | Seref istek | marketed | Osmotic agent | ||
| Mannitol Inhalant Product | Mannitol Inhalant Product | University of North Carolina, Chapel Hill | marketed | Osmotic agent / Airway clearance agent | ||
| Mannitol (Aridol) | Mannitol (Aridol) | University of Saskatchewan | marketed | Osmotic agent / Diagnostic bronchial challenge agent | ||
| NaCl 7.5% | NaCl 7.5% | Aristotle University Of Thessaloniki | marketed | Osmotic agent / Electrolyte solution | ||
| Mannitol Inhalation Kit | Mannitol Inhalation Kit | Dr. Diane Lougheed | marketed | Osmotic agent / Airway clearance therapy |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape (Osmotic agent class)
- Arbor Pharmaceuticals, Inc. · 1 drug in this class
- Innogene Kalbiotech Pte. Ltd · 1 drug in this class
- Medical University of Silesia · 1 drug in this class
- Seref istek · 1 drug in this class
- The Hospital for Sick Children · 1 drug in this class
- Université de Sherbrooke · 1 drug in this class
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Hypertonic saline 3% bolus administration CI watch — RSS
- Hypertonic saline 3% bolus administration CI watch — Atom
- Hypertonic saline 3% bolus administration CI watch — JSON
- Hypertonic saline 3% bolus administration alone — RSS
- Whole Osmotic agent class — RSS
Cite this brief
Drug Landscape (2026). Hypertonic saline 3% bolus administration — Competitive Intelligence Brief. https://druglandscape.com/ci/hypertonic-saline-3-bolus-administration. Accessed 2026-05-14.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab